Benefits

Dashboard

See Price & Plans

Not registered yet? Get a free account.

Concord Biotech Limited
Location
People
Financials
- Financial Highlights
- Balance Sheet
- Profit & Loss
- Ratios
Charges
Network
T. Score
Registered Details

CONCORD BIOTECH LIMITED

www.concordbiotech.com

All Companies ›

Gujarat ›

Manufacturing of Chemical Products ›

CONCORD BIOTECH LIMITED

Active

Updated: 14 Oct 2026

Concord Biotech Limited manufactures and supplies fermentation, semi-synthetic, and synthesis based biopharmaceuticals and active pharmaceutical ingredients.

Concord Biotech Limited, is a listed public company incorporated on 23 November, 1984. It is classified as a public limited company and is located in Ahmedabad, Gujarat. It's authorized share capital is INR 11.00 cr and the total paid-up capital is INR 10.46 cr.

Subscription Plans

Industry and products

Manufacturing of Pharmaceuticals

Cyclosporine A, Tacrolimus, Sirolimus, Mycophenolate mofetil, Mycophenolate sodium

Company size

Auth Capital

₹ 11.0 Cr

Paidup Capital

₹ 10.5 Cr

Revenue

₹ 1000-1250 cr

Key Metrics

** All rupee values in INR crores.

Total Revenue

-10.99%

₹ GET PRO

EBITDA

-25.63%

₹ GET PRO

Net Profit

-29.41%

₹ GET PRO

Networth

11.43%

₹ GET PRO

Borrowings

-100.0%

₹ GET PRO

Assets

9.95%

₹ GET PRO

Gross Margin

2.15

GET PRO %

Operating Margin

-6.5

GET PRO %

Net Profit Margin

-6.21

GET PRO %

Return on Equity

-7.55

GET PRO %

ROCE

-9.64

GET PRO %

Debt to Equity

GET PRO

Sales

Mar 2026

Net worth

Mar 2026

Buy Report or Plans

Dashboards

Popular Plan

Company dashboard

₹ 449
- Five year financials and ratios
- Risk analysis
- Interactive charts

Buy credits

View subscriptions

MCA Fillings

All financials

₹ 349
- All financials
- All annual returns
- MoA and AoA
1 Year

₹ 249
- Latest financials
- Latest annual return
- MoA and AoA

PDF Reports

Financial report

₹ 799
- Five year financials and ratios
- Shareholding and group structure
Financial+Litigation report

₹ 1299
- Everything in financial report
- Litigation report on the company
Due diligence report

₹ 2999
- Everything in financial+litigation report
- Peers and financials

* GST not included

** Reports & MCA filings will be based on the latest available financials.

** Delivery timelines are on best-effort basis during working hours. Filings 3-4 hours. Reports 24-48 hours.

Locations

India (7)

State	Type	Address

Locations on Map

People

Designation	Name	DIN/PAN	Tenure
Director	Arvind Motilal Agarwal Shareholder	00122921	4 years
Director	Ravi Kapoor	00003847	23 years
Director	Rajiv Ambrish Agarwal Shareholder	00379990	17 years
Managing Director	Ankur Vaid Shareholder	01857225	11 years
Managing Director	Sudhir Jairam Vaid Shareholder	00055967	16 years
Director	Bharti Khanna	05147844	9 years
Director	Amitabh Gajendra Thakore Shareholder	00016715	9 years
Director	Jayaram Easwaran Shareholder	02241192	4 years
Director	Chakravarthy Sriraman Mandayam	09631555	4 years
Cfo	Ravirajbhai Ghanshyambhai Karia	05299023	1 years
Director	Ekta Gupta	01095961	0 years

Financial Highlights

Financials upto March 2026 available in Tofler Pro

	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Sales	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Operating profit	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Net profit	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Gross margin	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Operating margin	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Net margin	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Networth
Borrowings	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Debt to equity	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Current ratio	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
ROE	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Days payable	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
WC days	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO

Margins

Gross margin

Operating margin

Net margin

Balance Sheet

Standalone

Consolidated

₹

Financials upto March 2026 available in Tofler Pro

	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Reserves	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Borrowings +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Long term borrowings	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Short term borrowings	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Trade payables +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Days payable	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other liabilities +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other non-current liabilities	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other current liabilities	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Total liabilities	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Fixed Assets +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Tangible assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
CWIP	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Intangible assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
LT loans and advances	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other non-current assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Current assets +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Inventories	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Trade receivables	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Cash and cash equivalents	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
ST loans and advances	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other current assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Total assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO

Percentage of assets	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Reserves	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Borrowings +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Long term borrowings	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Short term borrowings	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Trade payables	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other liabilities +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other non-current liabilities	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other current liabilities	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Total liabilities	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Fixed Assets +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Tangible assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
CWIP	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Intangible assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
LT loans and advances	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other non-current assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Current assets +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Inventories	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Trade receivables	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Cash and cash equivalents	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
ST loans and advances	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other current assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Total assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO

	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	9.5	10.5	10.5	10.5	10.5
Reserves	1,093.7	1,279.5	1,516.2	1,802.3	2,004.7
Borrowings +	60.6	31.2	6.2	0.4	-
Long term borrowings	31.2	6.2	-	-	-
Short term borrowings	29.3	25.0	6.2	0.4	-
Trade payables +	83.1	93.8	94.4	113.0	101.9
Days payable	185.0	190.0	150.0	135.0	151.0
Other liabilities +	65.9	98.9	73.4	108.1	117.7
Other non-current liabilities	23.2	25.9	31.9	37.5	50.5
Other current liabilities	42.7	73.0	41.5	70.6	67.2
Total liabilities	1,312.8	1,514.0	1,700.7	2,034.3	2,234.7
Fixed Assets +	647.1	765.4	783.5	843.1	865.7
Tangible assets	569.4	592.5	571.7	791.8	785.7
CWIP	74.2	172.7	211.5	50.7	79.3
Intangible assets	3.6	0.2	0.3	0.6	0.7
LT loans and advances	-	-	-	-	-
Other non-current assets	33.0	20.9	20.9	56.0	118.9
Current assets +	632.7	727.7	896.2	1,135.2	1,250.1
Inventories	195.1	212.3	208.0	239.7	326.4
Trade receivables	232.2	273.8	349.6	521.7	460.2
Cash and cash equivalents	0.7	3.5	15.1	0.9	12.2
ST loans and advances	-	-	-	-	-
Other current assets	204.7	238.1	323.5	373.0	451.4
Total assets	1,312.8	1,514.0	1,700.7	2,034.3	2,234.7

Percentage of assets	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	0.72	0.69	0.62	0.51	0.47
Reserves	83.31	84.51	89.15	88.6	89.71
Borrowings +	4.62	2.06	0.37	0.02	0.0
Long term borrowings	2.38	0.41	0.0	0.0	0.0
Short term borrowings	2.23	1.65	0.37	0.02	0.0
Trade payables	6.33	6.2	5.55	5.56	4.56
Other liabilities +	5.02	6.54	4.32	5.31	5.27
Other non-current liabilities	1.76	1.71	1.88	1.84	2.26
Other current liabilities	3.25	4.82	2.44	3.47	3.01
Total liabilities
Fixed Assets +	49.29	50.56	46.07	41.44	38.74
Tangible assets	43.37	39.14	33.62	38.92	35.16
CWIP	5.65	11.41	12.43	2.49	3.55
Intangible assets	0.27	0.01	0.02	0.03	0.03
LT loans and advances	0.0	0.0	0.0	0.0	0.0
Other non-current assets	2.51	1.38	1.23	2.75	5.32
Current assets +	48.19	48.07	52.7	55.81	55.94
Inventories	14.86	14.02	12.23	11.78	14.6
Trade receivables	17.69	18.08	20.56	25.64	20.59
Cash and cash equivalents	0.05	0.23	0.89	0.04	0.55
ST loans and advances	0.0	0.0	0.0	0.0	0.0
Other current assets	15.59	15.73	19.02	18.34	20.2
Total assets

Total assets

Charges on assets

Bank wise

Charges

Axis Bank Limited

No. of Loans: 1

Total Amount : 45.0 cr

Charge Holder	Amount	Date of creation/modification
Axis Bank Limited	45.0 cr	31 Jul, 2023

Charges

Axis Bank Limited

Company Network

Companies connected through Directors

Name	Status	Paid up Capital	Common Directors	Address
SADBHAV HYBRID ANNUITY PROJECTS LIMITED	Active	5.0 L	1	Delhi
CORONEY TECHNOLOGIES PRIVATE LIMITED	Active	1.1 L	1	Gujarat
ADANI GREEN ENERGY (UP) LIMITED	Active	5.0 L	1	Gujarat
KODANGAL SOLAR PARKS PRIVATE LIMITED	Active	21.0 L	1	Telangana
LNR IPR SOLUTIONS LLP	Active	1.0 L	1	Gujarat
AMITY CONSULTANTS LLP	Active	7.6 L	1	Gujarat
YAN ADVISORY SERVICES LLP	Active	8.5 L	1	Gujarat
KRV INSOLVENCY PROFESSIONALS LLP	Strike Off	1.0 L	1	Gujarat
SANGHI INDUSTRIES LIMITED	Active	2,458.3 Cr	1	Telangana
CONCORD BIOTECH LIMITED	Active	10.5 Cr	9	Gujarat
MARINE INFRASTRUCTURE DEVELOPER PRIVATE LIMITED	Active	400.0 Cr	1	Tamil Nadu
WARDHA SOLAR (MAHARASHTRA) PRIVATE LIMITED	Active	277.0 Cr	1
ORIENT CEMENT LIMITED	Active	20.5 Cr	1	Odisha
ADANI WIND ENERGY (GUJARAT) LIMITED	Active	530.0 Cr	1	Gujarat
BIOMIX NETWORK LIMITED	Active	10.0 L	1	Maharashtra
SUDMAN CONSULTANTS PRIVATE LIMITED	Converted to LLP and Dissolved	1.5 L	2	Gujarat
SUDMAN CONSULTANTS LLP	Active	1.5 L	2	Gujarat
GUJARAT SMALL INDUSTRIES CORPN LIMITED	Under Liquidation	4.0 Cr	1	Gujarat
KLJ ORGANIC LIMITED	Active	10.0 Cr	1	Delhi
TIGER CONSULTANCY LLP	Active	5.0 L	1	Maharashtra
HUNGAMA DIGITAL MEDIA ENTERTAINMENT PRIVATE LIMITED	Active	16.8 Cr	1
ALCHEMY CAPITAL MANAGEMENT PRIVATE LIMITED	Active	75.2 L	1
HUNGAMA .COM PRIVATE LIMITED	Amalgamated	1.6 Cr	1	Maharashtra
EQUIRUS CAPITAL PRIVATE LIMITED	Active	36.5 Cr	1	Maharashtra
APTECH LIMITED	Active	58.0 Cr	1	Maharashtra
FULLIFE HEALTHCARE PRIVATE LIMITED	Active	10.3 Cr	1	Maharashtra
AEQUITAS FINANCIAL SERVICES LIMITED	Strike Off	5.0 L	1	Telangana
ANITHA RAVI SANGHI'S FOUNDATION	Active	1.0 L	1	Telangana
SANGHI HILLS LLP	Active	10.0 L	1	Telangana
SANGHI POLYMERS PRIVATE LIMITED	Active	1.0 Cr	1	Telangana
CELLIIMUNE BIOTECH PRIVATE LIMITED	Active	66.0 L	1	Gujarat
SOULS SUCCEEDABILITY SOLUTIONS & SERVICES PRIVATE LIMITED	Strike Off	1.0 L	1	Karnataka
JINDAL STAINLESS (HISAR) LIMITED	Amalgamated	47.2 Cr	1	Haryana
AMARANT LIFESCIENCES PRIVATE LIMITED	Active	1.0 L	1	Delhi

Tofler Score

Poor

Fair

Good

Very Good

Excellent

Risk

Severe Risk

No risks identified

Moderate Risk

No risks identified

Low Risk

No risks identified

About Tofler Score

Tofler Score measures the quality of performance and integrity of a company. It is dependent on three key factors - Sustainability, Governance, and Growth.

CIN

L24230GJ1984PLC007440

Incorporation

1984, 41.9 years

Company Email

finance@concordbiotech.com

Paid up Capital

₹ 10.5 Cr

Authorised Capital

₹ 11.0 Cr

AGM

Jul 2026

Type

Public

Others

FAQ - CONCORD BIOTECH LIMITED

What is the incorporation date of CONCORD BIOTECH LIMITED?

The incorporation date of CONCORD BIOTECH LIMITED is 23 November, 1984

What is the authorized share capital of CONCORD BIOTECH LIMITED?

The authorized share capital of CONCORD BIOTECH LIMITED is INR ₹ 11.0 Cr.

What is the paid-up capital of CONCORD BIOTECH LIMITED?

The paid-up capital of CONCORD BIOTECH LIMITED is INR ₹ 10.5 Cr.

What is the registered address of CONCORD BIOTECH LIMITED?

The registered address of CONCORD BIOTECH LIMITED is 1482-86 TRASAD ROAD DHOLKA AHMEDABAD Gujarat - 387810

What is the CIN number of CONCORD BIOTECH LIMITED?

The CIN number of CONCORD BIOTECH LIMITED is L24230GJ1984PLC007440.

Smart Suggestions

Uttar Pradesh
Haryana
Jammu & Kashmir
Punjab
Goa
Madhya Pradesh
Kerala
Gujarat
Andhra Pradesh
Telangana
Blog Categories
Top Blog post
Financial Resources

Tofler, TWS Systems Private Limited and its officers respect the Intellectual Property Rights of all people. Tofler makes no claim of ownership or affiliation with any trademark (REGISTERED OR UNREGISTERED) that forms part of any Company/LLP name listed on this page. Trademarks, if any, listed on this page belong to... Read More

CONCORD BIOTECH LIMITED

Leave site?

Buy Dashboard using Credits

Just a Quick Check!

Buy Report or Plans

Dashboards

Company dashboard

Buy credits

View subscriptions

MCA Fillings

All financials

1 Year

PDF Reports

Financial report

Financial+Litigation report

Due diligence report

Choose number of credits to buy

₹ 449 + GST

Locations

Locations on Map

Filter (4)

Select Tags

Choose Location

People

Financial Highlights

Margins

Balance Sheet

Total assets

Charges on assets

Charges

Company Network